Can a drug for muscle weakness help save sight in optic neuritis?
NCT ID NCT06453694
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests efgartigimod alfa (Vyvgart Hytrulo) against placebo in 20 adults having their first episode of moderate to severe optic neuritis, an inflammation of the optic nerve that can cause vision loss. Participants get two injections over a week, plus standard steroid treatment, and are followed for 6 months. The main goal is to see if a larger trial is feasible and whether the drug improves vision recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- efgartigimod alfa (Vyvgart Hytrulo)
- What this could lead to
- If this works, it could point toward a new treatment to help people recover vision faster after optic neuritis.
- What could go wrong
- This is a very small, early pilot trial with only 20 people. It's mainly checking if a larger study is possible, not yet proving the drug works. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts Eye and Ear Infirmary
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic clues may forecast multiple sclerosis after vision loss
- New eye test criteria could speed up diagnosis of vision loss cause
- New drug aims to save sight in optic neuritis patients
- Eye camera spots hidden inflammation in MS patients
- Can a common antihistamine help heal the optic nerve?
- Scientists launch major effort to unravel mysteries of rare brain and spinal cord diseases